The study, which launched July 24, is open to all Florida residents who are at least 18 years old. Through the project, AdventHealth Orlando, part of Altamonte Springs, Fla.-based AdventHealth system, aims to study how genomics can help prevent, diagnose and treat diseases.
Participants’ DNA will be evaluated for genes linked to familial hypercholesterolemia, a genetic condition also known as FH that causes high cholesterol. Individuals who participate in the project will also get information regarding their ancestry traits as well as 22 personal genetic traits, including lactose tolerance, delayed sleep and earwax type.
Data collected through the study will be stored in a repository that meets HIPAA security standards as well as local, state and federal laws, according to AdventHealth Orlando’s website.
More articles on health IT:
Livongo Health values company at $2.5B upon IPO
CHIME asks Congress to fund nationwide patient identifier
6 hospitals, health systems report cyberattacks in the past 30 days
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
